Tissue Distribution Imaging

Tissue distribution imaging visualises pharmaceutical localisation employing radiolabeling or fluorescence. Positron emission tomography enables high-sensitivity imaging. Single-photon emission computed tomography provides tomographic imaging. Fluorescence microscopy reveals cellular localisation. Biodistribution prediction informs toxicity assessment.

Regulatory submissions incorporate imaging findings. Organ-specific accumulation guides safety assessment. Targeted delivery validation employs imaging. Post-approval monitoring confirms predicted distribution. Emerging technologies improve imaging specificity.